» Articles » PMID: 37669051

Reproductive Factors and Endometrial Cancer Risk Among Women

Abstract

Importance: Despite evidence of an association between reproductive factors and endometrial cancer risk, prospective studies have been conducted mainly in non-Asian countries.

Objective: To assess the association between reproductive factors, such as number of deliveries, age at menarche, or menopause, and endometrial cancer risk.

Design, Setting, And Participants: This cohort study used pooled individual data from 13 prospective cohort studies conducted between 1963 and 2014 in the Asia Cohort Consortium. Participants were Asian women. Data analysis was conducted from September 2019 to April 2023.

Exposures: Reproductive factors were assessed using a questionnaire in each cohort.

Main Outcomes And Measures: The main outcome was time to incidence of endometrial cancer. A Cox proportional hazards model was used to calculate hazard ratios (HRs) and 95% CIs.

Results: A total of 1005 endometrial cancer cases were detected among 332 625 women (mean [SD] age, 54.3 [10.4] years) during a mean (SD) of 16.5 (6.4) years of follow-up. Increasing number of deliveries was associated with a decreased endometrial cancer risk in a dose-response manner (≥5 deliveries vs nulliparous [reference]: HR, 0.37; 95% CI, 0.26-0.53; P for trend < .001). Compared with menarche at younger than 13 years, menarche at 17 years or older had an HR of 0.64 (95% CI, 0.48-0.86; P for trend < .001). Late menopause (age ≥55 years) showed an HR of 2.84 (95% CI, 1.78-4.55; P for trend < .001) compared with the youngest age category for menopause (<45 years). Age at first delivery, hormone therapy, and breastfeeding were not associated with endometrial cancer risk.

Conclusions And Relevance: This large pooled study of individual participant data found that late menarche, early menopause, and a higher number of deliveries were significantly associated with a lower risk of endometrial cancer. These convincing results from Asian prospective studies add to the growing body of evidence for the association between reproductive factors and endometrial cancer.

Citing Articles

Global Trends in Incidence and Mortality Rates of Endometrial Cancer Among Individuals Aged 55 years and Above From 1990 to 2021: An Analysis of the Global Burden of Disease.

Gao S, Wang J, Li Z, Wang T, Wang J Int J Womens Health. 2025; 17:651-662.

PMID: 40066179 PMC: 11892492. DOI: 10.2147/IJWH.S499435.


The influence of menopause age on gynecologic cancer risk: a comprehensive analysis using NHANES data.

Abulajiang Y, Liu T, Wang M, Abulai A, Wu Y Front Oncol. 2025; 15:1541585.

PMID: 40007994 PMC: 11851290. DOI: 10.3389/fonc.2025.1541585.


Distribution and Related Influencing Factors of AMH Level in Family-Planning Women of Childbearing Age: A Cross-Sectional Study from Beijing, China.

Song J, Gao S, Zhao L, Tong X Int J Womens Health. 2025; 17:99-107.

PMID: 39866819 PMC: 11766139. DOI: 10.2147/IJWH.S499220.


Is Insulin Resistance a High-Risk Factor for Postmenopausal Endometrial Cancer: Insights from the Triglyceride Glucose (TyG) Index and the Metabolic Score for Insulin Resistance (METS-IR).

Gao S, Wang J, Wang T, Wang J Int J Womens Health. 2025; 16:2355-2363.

PMID: 39742345 PMC: 11687295. DOI: 10.2147/IJWH.S500936.


Reproductive factors and risk of epithelial ovarian cancer: results from the Asia Cohort Consortium.

Merritt M, Abe S, Islam M, Rahman M, Saito E, Katagiri R Br J Cancer. 2024; 132(4):361-370.

PMID: 39706987 PMC: 11833059. DOI: 10.1038/s41416-024-02924-z.


References
1.
. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. Lancet. 2019; 394(10204):1159-1168. PMC: 6891893. DOI: 10.1016/S0140-6736(19)31709-X. View

2.
Tsugane S, Sawada N . The JPHC study: design and some findings on the typical Japanese diet. Jpn J Clin Oncol. 2014; 44(9):777-82. DOI: 10.1093/jjco/hyu096. View

3.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

4.
Kweon S, Shin M, Jeong S, Nam H, Lee Y, Park K . Cohort Profile: The Namwon Study and the Dong-gu Study. Int J Epidemiol. 2013; 43(2):558-67. DOI: 10.1093/ije/dys244. View

5.
Zheng W, McLerran D, Rolland B, Zhang X, Inoue M, Matsuo K . Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med. 2011; 364(8):719-29. PMC: 4008249. DOI: 10.1056/NEJMoa1010679. View